DEC Treatment of Non-Nematodal Infections

Tropical Doctor

Volumn 26, Issue 2, 1996, Pages 55-57

  Mejia C R ^a   Hernandez J E ^a   Kitchen, L W ^b  

^a Asociación Guatemalteca para la Prevención y Control del SIDA   (Guatemala)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; DIETHYLCARBAMAZINE; ETHAMBUTOL; ISONIAZID; SULFAMETHOXAZOLE; TRIMETHOPRIM; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL INFECTION; CANDIDA; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MYCOBACTERIUM; MYCOSIS; PNEUMOCYSTIS CARINII; PSEUDOMONAS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; CANDIDIASIS; DIETHYLCARBAMAZINE; FEMALE; FILARICIDES; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOSES; PNEUMONIA, PNEUMOCYSTIS; PSEUDOMONAS INFECTIONS;

EID: 0030011010     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559602600204     Document Type: Article

References (12)

1. Nelson P, Sellon R, Novotney C, et al. Therapeutic effects of diethylcarbamazine and 3′-azido-3′-deoxythymidine on feline leukemia virus lymphoma formation. Vet Immunol Immunopathol. 1995; 46: 181–94
2. Kitchen LW, Ross JA, Turner GJ, Hernández JE, Mather FJ. Diethylcarbamazine enhances blood microbicidal activity. Adv Ther. 1995; 12: 22–9
3. Arathoon EG, Mejía CR, Martín RM Estrada, Hernández JE, Turner GJ, Kitchen LW. Serum HIV-1 p24 levels and body weight measurements before and after 4 weeks of diethylcarbamazine treatment given to HIV-1 seropositive persons. Int J Antimicrob Agents. 1994; 3: 275–8
4. Kitchen LW, Ross JA, Hernández JE, Zarraga AL, Mather FJ. Effect of administration of diethylcarbamazine on experimental bacterial and fungal infections in mice. Int J Antimicrob Agents. 1992; 1: 259–67
5. Kitchen LW, Ross JA, Hernández JE, Zarraga AL, Mather FJ. Effect of administration of diethylcarbamazine with and without fluconazole on experimental fungal infections in mice. Int J Antimicrob Agents. 1993; 2: 237–46
6. Kitchen LW. Non-nematodal anti-infective effects of diethylcarbamazine: a meta-analytic review. Adv Ther. 1995; 12: 277–82
7. Kitchen LW, Hernández JE. Diethylcarbamazine treatment of TB-inoculated mice: preliminary experiment [Abstract]. In: The Challenge of Tuberculosis Conference September 14–15, 1995, Washington DC. London: Lancet, 1995:43
8. Hawking F, Sewell P, Thurston JP. The mode of action of hetrazan on filarial worms. Br J Pharmacol. 1950; 5: 217–38
9. Addiss DG, Dimock KA, Eberhard ML, Lammie PJ. Clinical, parasitologic, and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis. J Infect Dis. 1995; 171: 755–8
10. Kitchen LW, Hernández JE, Zarraga AL. Diethylcarbamazine treatment of chronic osteomyelitis. Compl Ortho. 1995; 10: 47–9
11. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. J Am Med Assoc. 1993; 269: 2853–9
12. UNDP, World Bank, World Health Organization. Salt-shakers join war on elephantiasis. Special Program for Research and Training in Tropical Diseases. TDR News. 1994; July (available via Internet)